Interestingly, however, CHD4 expression was significantly higher in platinum-resistant cases (p = 0.033), suggesting that CHD4 overexpression had the potential to lead platinum resistance in patients with ovarian cancer (Fig 1B). This evidence concerns the gene CHD4 and ovarian cancer.